Centene Corp (CNC) Gets a Buy Rating from Cantor Fitzgerald


In a report released today, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Centene Corp (CNC), with a price target of $145. The company’s shares opened today at $132.87.

Halper observed:

“We rate Centene Corporation (CNC) DCF-based price target of $145 per share. We continue to view Medicaid as a good growth opportunity. At the same time, CNC is building its Medicare Advantage business, increasing its footprint in individual exchange markets (and doing it profitably) and increasing its specialty offerings. $145 per share 12-month price target is based on DCF analysis.”

According to TipRanks.com, Halper is a top 25 analyst with an average return of 19.5% and a 67.8% success rate. Halper covers the Services sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Hms Holdings Corp.

Currently, the analyst consensus on Centene Corp is a Strong Buy with an average price target of $161.57.

See today’s analyst top recommended stocks >>

The company has a one-year high of $148.98 and a one-year low of $94.69. Currently, Centene Corp has an average volume of 1.48M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts